6.46
Adial Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
4.78
FY23:
3.20
FY24:
4.06
FY25:
6.18
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.01
FY22:
0.95
FY23:
1.54
FY24:
0.99
FY25:
0.49
Total assets
Change from FY21 to FY25
millions USD
FY21:
7.47
FY22:
5.73
FY23:
4.74
FY24:
5.04
FY25:
6.67
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.72
FY22:
1.79
FY23:
0.65
FY24:
0.98
FY25:
1.40
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.24
FY22:
0.67
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.51
FY22:
3.28
FY23:
4.08
FY24:
4.07
FY25:
5.28
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
7.47
FY22:
5.73
FY23:
4.74
FY24:
5.04
FY25:
6.67
All amounts in millions USD